Compugen Ltd. (USA) (NASDAQ:CGEN)

CAPS Rating: 4 out of 5

A biotechnology discovery company focused on discovering and licensing of product candidates to the drug and diagnostic industry.

Recs

0
Player Avatar bIlluminati (30.73) Submitted: 7/25/2012 2:02:54 PM : Underperform Start Price: $3.36 CGEN Score: +4.65

Looks like it will need to sell new shares.

Report this Post Reply

Featured Broker Partners


Advertisement